Cream-balm "Barrier"

Cream-balm "Barrier" Cream-balm "Barrier"

Cream-balm "Barrier" has preventive protivogrippoznoe, antiviral effect. It has a pronounced anti-bacterial and anti-fungal properties. Cream-balm "Barrier" natural antibiotic - even topical application of the cream increases the body's resistance to infectious and seasonal colds.

Cream-balm "Barrier" is the prevention of SARS and ARI during seasonal infections. Runny nose, colds and viral nature. Inflammation of the middle ear, boils hearing prohoda.Tak same cream-balm "Barrier" helps with headaches, vascular spasms, the noise in my head. Cream-balm "Barrier" promotes the accelerated healing of wounds, minor cuts, scrapes. It relieves inflammation of the superficial layers of the skin neuro-allergic nature. Sciatica - rubbing the problem areas a small amount of cream and followed by heating gives lasting anti-inflammatory effect. Prevention of periodontal disease and bleeding gums - one of the useful properties of a cream-balm "barrier". Dermatophytosis - excessive sweating legs, itching, inflammation of the skin between the toes, feet fungal infection of the foot.

Manufacturer: TM Ekolyuks, Ukraine
Ingredients: beeswax, propolis, green walnut oil, garlic, pine needles, ginger, essential oils of tea tree, alpine fir, lavender
How to use: for colds - Cream-balm "Barrier" is applied to the "zone of mustard plasters", avoiding the heart, rubbed up thermoeffect. Insulate, leave overnight. 2-3 times a day, put on the area of the maxillary sinus, frontal sinus, area of almonds (neck). When colds are accompanied by headaches, do head massage, cream-balm applied to the hands and fingers to massage the whole head. In skin diseases and fungal - applied to the affected body areas 2-3 times a day. When the complex epidemiological situation (threat of influenza, acute respiratory disease, SARS) to carry out a cream-balm reorganization of the nasal passages, each time entering the street
Contraindications: idiosyncrasy
Packing: 20 ml
Shelf life: 12 months
Certificate: c-d conclusion from 18.10.2010 №05.03.02-04 \ 77423

Login to post comments
back to top